Sildenafil: clinical trials recruiting now
3
Recruiting trials
6
Conditions studied
0
US states with sites
3
Countries
FDA drug label
- FDA-approved
- Yes. Sildenafil appears in the FDA drug-label database. Marketed as Sildenafil Citrate.
FDA-approved use
Sildenafil citrate is indicated for the treatment of erectile dysfunction. Sildenafil citrate is a phosphodiesterase-5 (PDE5) inhibitor indicated for the treatment of erectile dysfunction (ED) ( 1 )
Phase breakdown
Phase 2 1
Phase 3 1
Phase 4 1
Conditions being studied
| Condition | Trials |
|---|---|
| Colorectal cancer | 1 |
| Digital Ulcers in Systemic Sclerosis | 1 |
| Erectile Dysfunction Following Radical Prostatectomy | 1 |
| Multiple sclerosis | 1 |
| Prostate cancer | 1 |
| Rectal Cancer | 1 |
Recruiting trials involving Sildenafil
- Interest of Early Erectile Rehabilitation With Sildenafil After Radiotherapy and Proctectomy for Rectal Cancer
- PEnile ReHABilitation After Nerve Sparing Robot-assisted Radical Prostatectomy for Prostate Cancer 2.0 (PEHAB-II)
- Safety and Tolerability of TOP-N53 Applied on Digital Ulcers in Patients With Systemic Sclerosis
Common questions
Is Sildenafil FDA-approved?
Yes, marketed as Sildenafil Citrate.
How many recruiting trials involve Sildenafil?
3 recruiting trials across 6 conditions.
Is this list of trials complete?
No. For the full record, search ClinicalTrials.gov.